Emergency versus elective living-donor liver transplantation: a comparison of a single center analysis

[1]  P. Kamath,et al.  Acute-on chronic liver failure. , 2012, Journal of hepatology.

[2]  I. Endo,et al.  Pathogenesis in ABO incompatible liver transplantation: a clinicohistological evaluation of four patients , 2010, Clinical transplantation.

[3]  B. Guglielmo,et al.  Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation , 2010, Transplant infectious disease : an official journal of the Transplantation Society.

[4]  Lu Shi-chun,et al.  Emergent right lobe adult‐to‐adult living‐donor liver transplantation for high model for end‐stage liver disease score severe hepatitis , 2010, Transplant international : official journal of the European Society for Organ Transplantation.

[5]  H. Okajima,et al.  Current status of organ transplantation in Japan and worldwide , 2010, Surgery Today.

[6]  I. Endo,et al.  A survival case of ABO-incompatible liver transplantation complicated with severe preoperative infection and subsequent overwhelming postsplenectomy infection. , 2009, Transplantation proceedings.

[7]  M. Enne,et al.  Living donor liver transplantation for acute liver failure: a single center experience. , 2009, Transplantation proceedings.

[8]  H. Hirasawa,et al.  Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[9]  H. Geiss,et al.  A Risk Profile for Invasive Aspergillosis in Liver Transplant Recipients , 2009, Infection.

[10]  M. Makuuchi,et al.  Living donor liver transplantation for fulminant hepatic failure , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[11]  A. Lok,et al.  Outcomes of living donor liver transplantation for acute liver failure: The adult‐to‐adult living donor liver transplantation cohort study , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  H. Nakasone,et al.  False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. , 2007, The Journal of antimicrobial chemotherapy.

[13]  I. Endo,et al.  A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation. , 2007, Transplantation proceedings.

[14]  T. Hirai,et al.  Risk factors for invasive aspergillosis in living donor liver transplant recipients , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[15]  C. Ahn,et al.  Pulmonary complications following adult liver transplantation. , 2006, Transplantation proceedings.

[16]  M. S. Mandell.  Hepatopulmonary syndrome and portopulmonary hypertension in the model for end‐stage liver disease (MELD) era , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  I. Endo,et al.  Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure. , 2004, Transplantation proceedings.

[18]  P. Tam,et al.  Live donor liver transplantation for fulminant hepatic failure in children , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  S. Fan,et al.  Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure , 2003, Transplantation.

[20]  P. Martín-Dávila,et al.  Risk factors for invasive aspergillosis in liver transplant recipients , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  C. Lo,et al.  Right‐lobe live donor liver transplantation improves survival of patients with acute liver failure , 2002, The British journal of surgery.

[22]  Koji Hashimoto,et al.  Living-donor liver transplantation for fulminant hepatic failure in adult patients with a left-lobe graft. , 2002, Surgery.

[23]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  P. de Mol,et al.  Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage Fluid , 2001, Journal of Clinical Microbiology.

[25]  S. Uemoto,et al.  Living donor liver transplantation for fulminant hepatic failure. , 2000, Transplantation.

[26]  L. Rink,et al.  Dysregulation between TH1 and TH2 T cell subpopulations in the elderly , 1996, Mechanisms of Ageing and Development.

[27]  M. Samore,et al.  Risk factors for invasive fungal infections complicating orthotopic liver transplantation. , 1994, The Journal of infectious diseases.

[28]  A. Iwama,et al.  Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy , 1993, European journal of haematology.

[29]  S. A. Kucharski.  Fulminant hepatic failure. , 1993, Critical care nursing clinics of North America.